Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center

Background/Objectives: Locally advanced and metastatic leiomyosarcoma (LMS) is an aggressive cancer with limited treatment options. This single-institution, retrospective study evaluated the efficacy of first-line chemotherapy regimens in patients with advanced or metastatic LMS treated at Stanford...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ted Kim, Clara Hao, Minggui Pan, Kristen N. Ganjoo, Nam Q. Bui
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-03-01
Edice:	Diseases
Témata:	leiomyosarcoma soft tissue sarcoma chemotherapy doxorubicin progression-free survival overall survival
On-line přístup:	https://www.mdpi.com/2079-9721/13/3/79
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!